Agency
Acariahealth Pharmacy 12 INC
Acariahealth Pharmacy 12 INC was paid $11.13M by Medicaid between Apr 2019 and Nov 2023, across 7 billing codes. Its largest line is J0585, Injection, onabotulinumtoxina, 1 unit — 45% of everything it billed.
33Billing provider infoACARIAHEALTH PHARMACY 12 INC
HAWTHORNE, NY 10532
HAWTHORNE, NY 10532
33aNPI1811206071assigned 10/05/2010
33bProvider typeHome Infusion Agency
28Total paid$11.13M
24GClaims8,476
24DCodes billed7
24AFirst – last monthApr 2019 – Nov 2023
Compared with peers
Next to other Home Infusion Agency providers in New York
Rank by total paid#4 of 14
Median peer was paid$525K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 459 | $761K | |
| 2020 | 1,922 | $2.93M | |
| 2021 | 2,814 | $3.73M | |
| 2022 | 1,976 | $2.15M | |
| 2023 | 1,305 | $1.56M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | 45% | 4,798 | 4,789 | $5.04M |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 27% | 1,810 | 1,735 | $2.95M |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 26% | 1,776 | 1,743 | $2.85M |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 1.7% | 29 | 25 | $184K |
| J0897 | Injection, denosumab, 1 mg | <1% | 37 | 37 | $49K |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | <1% | 14 | 12 | $45K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 12 | 12 | $12K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCICCOLELLA-KAHL, JESSICA (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Acariahealth Pharmacy #14, INC. | Sacramento, CA | $1.07M |
| Foundation Care LLC | Chesterfield, MO | $754K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.